AbbVie and Ichnos Glenmark sign licensing deal for trispecific antibody
Jezperklauzen/iStock via Getty Images AbbVie (NYSE:ABBV) and IGI Therapeutics SA, a unit of Ichnos Glenmark
Jezperklauzen/iStock via Getty Images AbbVie (NYSE:ABBV) and IGI Therapeutics SA, a unit of Ichnos Glenmark
hapabapa/iStock Editorial via Getty Images AbbVie (NYSE:ABBV) said it will incur a negative impact of
vzphotos/iStock Editorial via Getty Images AbbVie (NYSE:ABBV) has agreed to acquire clinical-stage biotechnology company Capstan
Johnson & Johnson (NYSE:JNJ) said that an advisory committee of the EU drug regulator, the
AbbVie (NYSE:ABBV) declares $1.64/share quarterly dividend, in line with previous. Forward yield 3.54% Payable Aug.
AntonioGuillem AbbVie (NYSE:ABBV) said on Wednesday that its late-stage study testing atogepant in comparison with
Michael Vi/iStock Editorial via Getty Images AbbVie (NYSE:ABBV) announced Monday a setback for a Phase
iQoncept/iStock via Getty Images The negative sentiment towards the S&P 500 Health Care Index Sector
vzphotos/iStock Editorial via Getty Images AbbVie (NYSE:ABBV) announced on Wednesday that the U.S. Food and
hapabapa AbbVie (NYSE:ABBV) continued gains for seven straight sessions, as the stock closed 1.3% higher